ClinVar Miner

Submissions for variant NM_015046.7(SETX):c.6248G>T (p.Arg2083Ile)

gnomAD frequency: 0.00001  dbSNP: rs751252138
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, Koc University RCV001095487 SCV001251081 uncertain significance Amyotrophic lateral sclerosis 2020-03-31 criteria provided, single submitter research
Labcorp Genetics (formerly Invitae), Labcorp RCV001212562 SCV001384150 uncertain significance Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 2019-09-27 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with SETX-related conditions. This variant is present in population databases (rs751252138, ExAC 0.006%). This sequence change replaces arginine with isoleucine at codon 2083 of the SETX protein (p.Arg2083Ile). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and isoleucine.
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital RCV002480462 SCV002775014 uncertain significance not provided 2022-12-17 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV003233948 SCV003931268 uncertain significance Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 2023-02-08 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV003233949 SCV003931269 uncertain significance Amyotrophic lateral sclerosis type 4 2023-02-08 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.